Search Results - platforms+%3e+drug+delivery+%3e+other+polymers

25 Results Sort By:
Novel Vaginal Drug Delivery Device (UCLA Case No. 2020-444)
Summary: UCLA researchers in the Departments of Biomedical Engineering and Medicine have developed vaginal drug delivery devices for the administration of contraceptives and antibiotics. Background: Globally, 1.9 billion women of reproductive age (15-49 years) use contraceptives. An additional 190 million women would use phrophylactics/contraceptives...
Published: 10/17/2024   |   Inventor(s): Leena Nathan, Song Li, Tamara Grisales, Mohammad Hasani-Sadrabadi
Keywords(s):  
Category(s): Platforms > Drug Delivery, Platforms > Drug Delivery > Antibody Delivery Platforms, Platforms > Drug Delivery > Other Polymers
Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery (UCLA Case No. 2021-116)
Summary: UCLA researchers in the department of Bioengineering have developed a biodegradable material that is capable of releasing insulin in the presence of excess glucose mimicking the insulin secretion properties of pancreatic B-cells as a treatment for Diabetes Mellitus.Background: Diabetes mellitus currently affects more than 463 million people...
Published: 8/9/2024   |   Inventor(s): Zhen Gu
Keywords(s):  
Category(s): Platforms > Drug Delivery > Other Polymers, Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Metabolism And Endocrinology
2020-854 DUAL SELF-REGULATED DELIVERY OF INSULIN AND GLUCAGON BY A HYBRID PATCH
UCLA researchers have developed a novel hybrid microneedle patch that can deliver insulin and glucagon in a glucose-dependent manner. BACKGROUND: Type I diabetes (T1D) is an autoimmune disease in which pancreatic -cells are destroyed and there is a deficiency is insulin secretion. Type 2 diabetes (T2D) is a metabolic disorder resulting from insulin...
Published: 7/19/2023   |   Inventor(s): Zhen Gu
Keywords(s): Drug Delivery, Medical Devices and Materials, Metabolic Diseases, Other Polymers, Polymers, Therapeutics & Vaccines
Category(s): Medical Devices, Platforms > Drug Delivery, Therapeutics, Platforms > Drug Delivery > Other Polymers, Therapeutics > Metabolism And Endocrinology
2013-741 Bioengineered Thymic Aggregates for Implantation
Bioengineered Thymic Aggregates For ImplantationSUMMARYResearchers led by Gay Crooks from the Department of Pathology and Laboratory Medicine at UCLA have bioengineered a thymus implant to treat immune diseases.BACKGROUNDThe thymus plays an important role in the immune cells by producing specialized white blood cells called T cells. Thymus implantation...
Published: 10/18/2024   |   Inventor(s): Gay Crooks, Amelie Montel Hagen, Brile Chung
Keywords(s): Autoimmune, Drug Delivery, Hematology, Inflammatory Diseases, Other Polymers, Therapeutics & Vaccines
Category(s): Platforms > Drug Delivery, Therapeutics > Autoimmune, Therapeutics > Hematology, Platforms > Drug Delivery > Other Polymers, Therapeutics > Immunology And Immunotherapy
Photocurable Poly(ethylene Glycol) as a Bioink for the Inkjet 3D Pharming of Hydrophobic Drugs
UC Case No. 2018-197SUMMARY: UCLA researchers in the Department of Bioengineering have developed a novel inkjet 3D pharming technique that is fast, customizable, and compatible with hydrophobic drugs. BACKGROUND: 3D pharming is an innovative technique that combines 3D printing and 2D material deposition to create personalized drug tablets that...
Published: 7/19/2023   |   Inventor(s): Benjamin Wu, Chase Linsley
Keywords(s): Drug Delivery, Other Polymers, PEG
Category(s): Platforms > Drug Delivery > Other Polymers, Platforms > Drug Delivery > PEG
2015-112 PolyProtek: Platform for Delivering and Stabilizing Therapeutic Biologics, Vaccines, and Industrial Enzymes
Summary UCLA researchers in the Department of Chemistry & Biochemistry have designed an improved version of trehalose-based glycopolymer as a degradable alternative to PEG for the purpose of stabilizing a protein during storage and transport. Background A UCLA team led by Professor Heather Maynard has developed a family of polymers that effectively...
Published: 7/19/2023   |   Inventor(s):  
Keywords(s):  
Category(s): Platforms > Drug Delivery > Other Polymers
2015-602 Update To Degradable Trehalose Glycopolymers
Summary UCLA researchers in the Department of Chemistry & Biochemistry have designed an improved version of trehalose-based glycopolymer as a degradable alternative to PEG for the purpose of stabilizing a protein during storage and transport. Background A UCLA team led by Professor Heather Maynard has developed a family of polymers that effectively...
Published: 7/19/2023   |   Inventor(s):  
Keywords(s):  
Category(s): Platforms > Drug Delivery > Other Polymers
2019-238 MIXTURES OF SYNTHETIC COPOLYPEPTIDE HYDROGELS
UCLA researchers in the Department of Bioengineering have developed a novel polypeptide-based hydrogel mixture that offers a large degree of biocompatibility and biodegradability while also offering the ability to tune mechanical properties. Specifically, these compositions allow for high hydrogel stiffness at low polymer concentrations, while retaining...
Published: 7/19/2023   |   Inventor(s): Timothy Deming
Keywords(s): Chemical Manufacturing & Industrial/Bulk Chemicals, Drug Delivery, Other Polymers
Category(s): Platforms > Drug Delivery > Other Polymers, Chemical > Industrial & Bulk Chemicals
2019-468 PERIODONTAL MICROPATCH AND USES THEREOF
INTRODUCTION:UCLA researchers in the Departments of Bioengineering and Dentistry have developed a patch-based drug delivery system for dental applications.BACKGROUND:Periodontitis is a chronic inflammatory disease that affects tissues surrounding the teeth, and it is estimated that 50% of the U.S. population suffers from some type of periodontal disease....
Published: 7/19/2023   |   Inventor(s):  
Keywords(s): Dental, Drug Delivery, Inflammatory Diseases, Medical Devices and Materials, Other Polymers
Category(s): Platforms > Drug Delivery > Other Polymers
2015-798 NONCRUSHABLE PILL FORMULATIONS
SUMMARY: UCLA Researchers in the Department of Chemistry have developed a drug formulation for opioids capable of deterring drug abuse. BACKGROUND: It is estimated that more than 115 Americans a day, died to opioid overdose in 2016. The currently projected estimate is that this number will increase to over 150 Americans a day fatally overdosing on opioids....
Published: 7/19/2023   |   Inventor(s): Heather Maynard, Erhan Bat
Keywords(s): Drug Delivery, Nanoparticles, Other Polymers
Category(s): Platforms > Drug Delivery > Other Polymers, Platforms > Drug Delivery > Nanoparticles
1 2 3